Binifibrate
Code | Size | Price |
---|
TAR-T26819-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26819-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26819-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Binifibrate is a hyperlipemiant drug used for the treatment of hyperlipidemia.
CAS:
69047-39-8
Formula:
C25H22ClN2O9
Molecular Weight:
529.91
Purity:
0.98
SMILES:
CC(Cc1ccncc1C([O-])=O)(Oc1ccc(Cl)cc1)C(=O)Oc1ccncc1C(=O)OCC(O)CO
References
1. Corominas Vilardell A, de Oya Otero M, Escobar Jim?nez F, Anguera Vila A, Ari?o Armengol B. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia]. An Med Interna. 1993 Nov;10(11):537-41. Spanish. PubMed PMID: 8117868.
2. Avellaneda A, Rueda A, Cascio C, Guti?rrez JA. [Changes in the lipid profiles of hyperlipemic patients treated with binifibrate]. An Med Interna. 1993 Jun;10(6):275-9. Spanish. PubMed PMID: 8334204.
3. S?nchez-Torres JM, Pedraz JL, Gasc?n AR, Bego?a Calvo M, Hern?ndez RM, Dom?nguez-Gil A. Biotransformation kinetic of binifibrate and identification of its metabolites. Boll Chim Farm. 1991 May;130(5):172-7. PubMed PMID: 1760151.
4. Dalmau M, Monasterio J, Nogu?s R, Pic? M, Freixes J, Bruseghini L, Diez S, Andreoli R. Microhaemorheological properties of binifibrate. Part II: Preliminary open studies in patients with peripheral arteriopathies. Arzneimittelforschung. 1983;33(6):858-61. PubMed PMID: 6684440.